Coverage
-
May 22, 2019
Pharmaceutical companies Amphastar, Sandoz and Momenta told a Massachusetts federal court that they have resolved their sprawling antitrust and patent battles over generic blood thinners, as long as the court agrees to nix Amphastar's win in the patent case.
11 other articles on this case.
View all »